Publications

Guillem Hurault, J-F. Stalder, M. Saint Aroman, R.J. Tanaka (2024). Data-driven personalised recommendations for eczema treatment using a Bayesian model of severity dynamics. medRxiv.

Code DOI

A. Duverdier, Guillem Hurault, K. Thomas, A. Custovic, R.J. Tanaka (2024). Evaluation of measurement errors in the Patient-Oriented Eczema Measure (POEM) outcome. Clinical and Experimental Allergy.

Cite Code DOI

R. Attar, Guillem Hurault, Z. Wang, R. Mokhtari, K. Pan, B. Olabi, E. Earp, L. Steele, H. C. Williams, R. J. Tanaka (2023). Reliable detection of eczema areas for fully automated assessment of eczema severity from digital camera images. JID Innovations.

Cite Code DOI MedRxiv

S. Haider, S. Fontanella, A. Ullah, S. Turner, A. Simpson, G. Roberts, C. S. Murray, J. W. Holloway, J. A. Curtin, P. Cullinan, S. H. Arshad, Guillem Hurault, R. Granell, A. Custovic, on behalf of STELAR/UNICORN11 investigators (2022). Evolution of Eczema, Wheeze and Rhinitis from Infancy to Early Adulthood: Four Birth Cohort Studies. American Journal of Respiratory and Critical Care Medicine.

Cite DOI

Guillem Hurault, J-F. Stalder, S. Mery, A. Delarue, M. Saint Aroman, G. Josse, R. J. Tanaka (2022). EczemaPred: A computational framework for personalised prediction of eczema severity dynamics. Clinical and Translational Allergy.

Cite Code DOI R Package

Guillem Hurault, K. Pan, R. Mokhtari, B. Olabi, E. Earp, L. Steele, H. C. Williams, R. J. Tanaka (2022). Detecting eczema areas in digital images: an impossible task?. JID Innovations.

Cite Code DOI MedRxiv

Guillem Hurault, E. Roekevisch, M.E. Schram, K. Szegedi, S. Kezic, M.A. Middelkamp-Hup, P.I. Spuls, R.J. Tanaka (2022). Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients?. Skin and Health Disease.

Cite Code DOI MedRxiv

Guillem Hurault, V. Delorieux, Y-M. Kim, K. Ahn, H. Williams, R.J. Tanaka (2021). Impact of environmental factors in predicting daily severity scores of atopic dermatitis. Clinical and Translational Allergy.

Cite Code DOI MedRxiv

J. G. Holm, Guillem Hurault, T. Agner, M. L. Clausen, S. Kezic, R. J. Tanaka, S. F. Thomsen (2021). Immunoinflammatory Biomarkers in Serum Are Associated with Disease Severity in Atopic Dermatitis. Dermatology.

Cite DOI

R. Jurakic Toncic, I. Jakasa, Y. Sun, Guillem Hurault, S. Ljubojevic Hadzavdic, R. J. Tanaka, S. Kezic, B. Marinovic (2021). Stratum corneum markers of innate and T helper cell-related immunity and their relation to the disease severity in Croatian patients with atopic dermatitis. Journal of the European Academy of Dermatology & Venereology.

Cite DOI

K. Pan, Guillem Hurault, K. Arulkumaran, H. Williams, R.J. Tanaka (2020). EczemaNet: Automating Detection and Severity Assessment of Atopic Dermatitis. MLMI: International Workshop on Machine Learning in Medical Imaging.

Cite Code DOI

J. Nousbeck, M.A. McAleer, Guillem Hurault, E. Kenny, K. Harte, S. Kezic, R.J. Tanaka, A.D. Irvine (2020). miRNA analysis of Childhood Atopic Dermatitis reveals a role for miR-451a. British Journal of Dermatology.

Cite DOI

Guillem Hurault, E. Domínguez-Hüttinger, S.M. Langan, H.C. Williams, R.J. Tanaka (2020). Personalised prediction of daily eczema severity scores using a mechanistic machine learning model. Clinical & Experimental Allergy.

Cite Code DOI MedRxiv

M.A. McAleer, I. Jakasa, Guillem Hurault, P. Sarvari, W.H.I. McLean, R.J. Tanaka, S. Kezic, A.D. Irvine (2019). Systemic and stratum corneum biomarkers of severity in infant AD include markers of innate and Th-related immunity and angiogenesis. British Journal of Dermatology.

Cite DOI

Guillem Hurault, M.E. Schram, E. Roekevisch, P.I. Spuls, R.J. Tanaka (2018). Relationship and probabilistic stratification of EASI and oSCORAD severity scores for atopic dermatitis. British Journal of Dermatology.

Cite Code DOI Web app